These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16616331)

  • 1. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity.
    Liu Y; Cheney MD; Gaudet JJ; Chruszcz M; Lukasik SM; Sugiyama D; Lary J; Cole J; Dauter Z; Minor W; Speck NA; Bushweller JH
    Cancer Cell; 2006 Apr; 9(4):249-60. PubMed ID: 16616331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity.
    Liu Y; Chen W; Gaudet J; Cheney MD; Roudaia L; Cierpicki T; Klet RC; Hartman K; Laue TM; Speck NA; Bushweller JH
    Cancer Cell; 2007 Jun; 11(6):483-97. PubMed ID: 17560331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-repressor CBFA2T2 regulates pluripotency and germline development.
    Tu S; Narendra V; Yamaji M; Vidal SE; Rojas LA; Wang X; Kim SY; Garcia BA; Tuschl T; Stadtfeld M; Reinberg D
    Nature; 2016 Jun; 534(7607):387-90. PubMed ID: 27281218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis.
    Sun XJ; Wang Z; Wang L; Jiang Y; Kost N; Soong TD; Chen WY; Tang Z; Nakadai T; Elemento O; Fischle W; Melnick A; Patel DJ; Nimer SD; Roeder RG
    Nature; 2013 Aug; 500(7460):93-7. PubMed ID: 23812588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.
    Chen MJ; Yokomizo T; Zeigler BM; Dzierzak E; Speck NA
    Nature; 2009 Feb; 457(7231):887-91. PubMed ID: 19129762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
    Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR
    Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming activity of AML1-ETO is independent of CBFbeta and ETO interaction but requires formation of homo-oligomeric complexes.
    Kwok C; Zeisig BB; Qiu J; Dong S; So CW
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2853-8. PubMed ID: 19202074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis.
    Yan M; Ahn EY; Hiebert SW; Zhang DE
    Blood; 2009 Jan; 113(4):883-6. PubMed ID: 19036704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC Inhibitors in Acute Myeloid Leukemia.
    San José-Enériz E; Gimenez-Camino N; Agirre X; Prosper F
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31739588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting FLT3 mutations in AML: review of current knowledge and evidence.
    Daver N; Schlenk RF; Russell NH; Levis MJ
    Leukemia; 2019 Feb; 33(2):299-312. PubMed ID: 30651634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTGR1 is required to maintain small intestinal stem cell populations.
    Short SP; Brown RE; Chen Z; Pilat JM; McElligott BA; Meenderink LM; Bickart AC; Blunt KM; Jacobse J; Wang J; Simmons AJ; Xu Y; Yang Y; Parang B; Choksi YA; Goettel JA; Lau KS; Hiebert SW; Williams CS
    Cell Death Differ; 2024 Sep; 31(9):1170-1183. PubMed ID: 39048708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis.
    Wu L; Huang J; Trivedi P; Sun X; Yu H; He Z; Zhang X
    Discov Oncol; 2022 Dec; 13(1):139. PubMed ID: 36520265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANTI-MTG16 ANTIBODIES REVEAL MTG16 SUBCELLULAR DISTRIBUTION AND NUCLEOCYTOPLASMIC TRANSPORT IN ERYTHROLEUKEMIA CELLS.
    Nguyen H; Mariotti J; Bareyan D; Carnahan R; Cooper T; Williams C; Engel M
    Antib Technol J; 2015; 5():27-41. PubMed ID: 36267145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation.
    Zhang YF; Wang XL; Xu CH; Liu N; Zhang L; Zhang YM; Xie YY; Zhang YL; Huang QH; Wang L; Chen Z; Chen SJ; Roeder RG; Shen S; Xue K; Sun XJ
    Front Cell Dev Biol; 2022; 10():992714. PubMed ID: 36158200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neurogenetic mechanism of experience-dependent suppression of aggression.
    Ishii K; Cortese M; Leng X; Shokhirev MN; Asahina K
    Sci Adv; 2022 Sep; 8(36):eabg3203. PubMed ID: 36070378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects.
    Gopalswamy M; Kroeger T; Bickel D; Frieg B; Akter S; Schott-Verdugo S; Viegas A; Pauly T; Mayer M; Przibilla J; Reiners J; Nagel-Steger L; Smits SHJ; Groth G; Etzkorn M; Gohlke H
    Sci Rep; 2022 Aug; 12(1):14158. PubMed ID: 35986043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD
    Feng P; Zhang J; Zhang J; Liu X; Pan L; Chen D; Ji M; Lu F; Li P; Li G; Sun T; Li J; Ye J; Ji C
    Front Cell Dev Biol; 2022; 10():842214. PubMed ID: 35656547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML nuclear body biogenesis and oligomerization-driven leukemogenesis.
    Li Y; Ma X; Meng G
    Blood Sci; 2020 Jan; 2(1):7-10. PubMed ID: 35399865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.